The Greek pharmaceutical company GENESIS Pharma ranked among the top 110 European companies in the European Business Awards 2014-15 sponsored by RSM, receiving the “Ruban d’ Honneur” honorary title and the ticket to the finals.
Selected as one of the 7 Greek finalists, GENESIS Pharma will now go on to compete in the third and final round of judging resulting in 11 overall category winners to be announced next June. Specifically, the company is nominated for “The Chairman's Selection” special excellence award, as chosen by a jury of distinguished representatives of the European academic and business community, for the strategy followed in crisis, managing to ensure sound business trend, growth prospects and all work positions.
The European Business Awards is one of the most renowned business institutions, which highlights and rewards business excellence and innovation across Europe. It is worth noting that in the 8th event this year, competition was extremely fierce as there was a record of participations: a total of 24,000 companies from 33 European countries took part, while 709 companies, including 60 Greek ones competed for the “Ruban d’ Honneur” title.